The tyrosine-based YXXØ targeting motif of murine leukemia virus envelope glycoprotein affects pathogenesis  by Danis, Carole et al.
www.elsevier.com/locate/yviro
Virology 324 (2004) 173–183The tyrosine-based YXXØ targeting motif of murine leukemia virus
envelope glycoprotein affects pathogenesis
Carole Danis,a Julie Deschambeault,a Sonia Do Carmo,b E´ric A. Cohen,a
E´ric Rassart,b and Guy Lemaya,*
aDe´partement de Microbiologie et Immunologie, Universite´ de Montre´al, Montre´al, Que´bec, Canada
bDe´partement des Sciences Biologiques, Universite´ du Que´bec a` Montre´al, Montre´al, Que´bec, CanadaReceived 10 December 2003; returned to author for revision 29 January 2004; accepted 12 March 2004Abstract
Retroviruses, such as human and simian immunodeficiency viruses (HIV and SIV), and murine leukemia viruses (MuLV), harbor a
tyrosine-based motif in the intracytoplasmic domain of their envelope glycoprotein. This motif can act as an endocytosis signal or as a
targeting signal, restricting viral budding at specific cell surface membrane domains. In the present study, proviral DNA of the ecotropic Cas-
Br-E strain of MuLV was modified by substitution or deletion of the critical tyrosine residue. Mutant viruses lost basolateral targeting in
polarized MDCK epithelial cells while expression level of the glycoprotein at the cell surface was not affected. This suggests that the
tyrosine-based motif in MuLV does not act as an endocytosis signal. Only a small delay in the appearance of disease was observed in
inoculated mice. In contrast, a striking change in the pathology was observed with enlarged thymus and lymph nodes in animals inoculated
with mutant viruses.
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Introduction the surface where most of their envelope glycoproteinIn the last few years, it has been realized that the
intracellular transport of viral protein components, as well
as viral assembly and release, is a tightly controlled process
that is affected by both viral and cellular factors. One of the
interesting aspects of these virus–cell interactions is the
transport, targeting, and control of steady-state cell surface
level of viral envelope glycoproteins. Many enveloped
viruses take advantage of the cellular protein transport
machinery to insert their envelope glycoproteins at specific
cell surface domains (Compans, 1995; Tucker and Com-
pans, 1993). In many cases, this probably facilitates viral
assembly and release in a ‘‘polarized’’ fashion from the cell
surface, although accumulating evidence indicates that
many viruses bud from cellular membranes distinct from0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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al., 1998; Mora et al., 2002; Sanger et al., 2001; Zimmer et
al., 2002; Zurzolo et al., 1992).
In retroviruses, numerous experimental evidence indi-
cate that viral release from polarized epithelial cells occurs
specifically from the basolateral membrane where targeted
delivery of the viral envelope glycoprotein also takes place
(Ball et al., 1997; Huang et al., 1999; Lodge et al., 1994,
1997a,1997b; Owens and Compans, 1989; Owens et al.,
1991; Roth et al., 1983). The targeting motif responsible
for basolateral transport is YXXØ (where Ø is a large
hydrophobic amino acid, a leucine residue in human
immunodeficiency virus, HIV-1, and murine leukemia
virus, MuLV) (Lodge et al., 1997a,1997b). The so-called
tyrosine-based motif was also shown to act as an endocy-
tosis signal in HIV-1, simian immunodeficiency virus
(SIV), and human T-cell leukemia virus (HTLV-I) (Ber-
lioz-Torrent et al., 1999; Boge et al., 1998; Bowers et al.,
2000; Egan et al., 1996; LaBranche et al., 1995; Marsh
and Pelchen-Matthews, 2000; Marsh et al., 1997; Ohno et
al., 1997; Sauter et al., 1996).
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tyrosine-based signal could also promote a polarization of
viral budding on lymphocytes where viral release occurs at a
restricted region that appears as crescent-shaped at one
‘‘pole’’ of the cell (Deschambeault et al., 1999; Fais et al.,
1995; LaBranche et al., 1995). It should also be stressed that
current thinking about cellular polarization suggests that
most cells exhibit polarization of their cell surface although
this is most easily demonstrated in certain cell types such as
epithelial or neuronal cells; the same signals could be used
and differentially interpreted in different cell types (Mostov
et al., 2003; Nelson, 2003).
The role of endocytosis and polarization signal in viral-
induced diseases is still largely unknown. In Sendai virus,
mutants altered in their apical polarization budding pheno-
type exhibit a striking difference in the disease that they
induce. Viruses that acquire the ability to bud from the
basolateral surface produce lethal systemic viremia in inoc-
ulated mice presumably by giving the virus an access to the
blood flow, in contrast wild-type apically restricted viruses
normally induce a viral pneumonia from which most ani-
mals recover (Tashiro et al., 1992). In retroviruses, in vitro
evidence suggested that the tyrosine-based motif promotes
viral transmission from infected to neighboring uninfected
cells in HIV-1 and HTLV-I. This is probably the result of
targeted viral budding at intercellular contact zone, thus
favoring viral propagation (Delamarre et al., 1999;
Deschambeault et al., 1999; Johnson and Huber, 2002).
Obviously, such a facilitated viral transmission could have
important consequences on viral spread in vivo. It is
believed that such an efficient cell-to-cell transmission is
mediated by a relocalization of cytoskeletal and membrane
proteins at specific sites of the plasma membrane, generat-
ing the so-called ‘‘virological synapse’’ (Derse and Hei-
decker, 2003; Dustin, 2003; Ikagura et al., 2003; Johnson
and Huber, 2002; McDonald et al., 2003). Basolateral
targeting of virus budding in epithelial cells could also be
of importance in the context of sexual transmission of the
virus at mucosal surfaces, by favoring viral release toward
cells and the blood flow underneath the epithelial surface, as
previously suggested (see, e.g., Bourinbaiar and Phillips,
1991; Pearce-Pratt and Phillips, 1993; Phillips and Bour-
inbaiar, 1992; Phillips et al., 1994; Tan et al., 1993). Finally,
it has been suggested that endocytosis of the viral envelope
glycoprotein from the cell surface, as well as any other
mechanism to ‘‘downmodulate’’ the glycoprotein from the
cell surface, could play a significant role in viral pathogen-
esis, by limiting cytopathogenicity as well as recognition of
infected cells by the immune system (Marsh and Pelchen-
Matthews, 2000; Marsh et al., 1997).
Despite this putative importance of the tyrosine-based
motif in retroviruses, there is only limited evidence that this
is actually the case in infected animals or humans. It has
been reported that alteration of the motif in bovine leukemia
virus could affect replication in vivo but also preclude
envelope incorporation into virions, although it is not thecase in other retroviruses (Inabe et al., 1999; Willems et al.,
1995). In a more recent study, it was reported that substi-
tution or deletion in the SIV tyrosine-based signal increases
latency for development of viral-induced disease in inocu-
lated macaques (Fultz et al., 2001).
Despite the interest of results obtained in the simian
model, there is a limitation in the number of animals that
could be easily studied, thus limiting its use in studies
involving multiple viral mutants. Because these animals
are not inbred, this further limits statistical analysis of the
data. In the present study, we examined the role of the
similar YXXØ motif present in murine leukemia virus
(MuLV) envelope glycoprotein as an alternative to study
the role of this motif in viral pathogenesis. Although
pathogenesis of MuLV is clearly distinct from that of HIV
or SIV, conservation of the YXXØ motif in different
retroviruses suggests common properties that are shared
by these viruses. Furthermore, the Cas-Br-E strain of MuLV
was chosen because it was shown to be sexually transmis-
sible (Portis et al., 1987), as are HIV and SIV.
Cas-Br-E viruses did not appear to exhibit any substantial
replication defect in vitro, upon inactivation of the tyrosine-
based motif by site-directed mutagenesis. However, a some-
what increased latency for disease development was ob-
served upon inoculation to newborn mice. In contrast to the
observations in SIV, there was no apparent reversion of the
introduced mutations; this could be due to a difference in the
overall role of the motif that does not seem to affect the cell
surface expression level of the murine virus envelope
glycoprotein. Most significantly, an important change in
viral-induced disease with involvement of additional organs
was noticed in mice that were inoculated with mutant
viruses rather than wild type. This further supports the
importance of the motif and associated functions in retrovi-
ral pathogenesis. This murine model thus appears to be well
suited to further comprehend the overall importance of the
tyrosine-based motif in replication, pathogenesis, and trans-
mission of a mammalian retrovirus.Results
Rationale
In an effort to establish an adequate model to study the
importance of the YXXØ motif in viral pathogenesis, we
took advantage of previous observations showing that
murine leukemia virus (MuLV), as other retroviruses, tend
to bud preferentially or exclusively from the basolateral
surface of epithelial cells (Lodge et al., 1997a; Roth et al.,
1983). The presence of a YXXØ motif was shown to be
responsible for the restricted viral budding at the basolateral
surface when the envelope glycoprotein from the Moloney
strain of MuLV was used to pseudotype envelope-negative
HIV-1 virions (Lodge et al., 1997a). The YXXØ motif is
strongly conserved in retroviruses of various animal species
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context that might affect its dual function (Eberle et al.,
1991; Matter et al., 1994). This conservation is also found in
murine retroviruses independently of their species tropism;
ecotropic, xenotropic, or amphotropic viruses all harbor the
motif at a similar position (Fig. 1A).
In the present study, the Cas-Br-E ecotropic strain of
MuLV was chosen to develop an animal model for the study
of the motif’s importance in viral replication, transmission,
and pathogenesis. The pathogenesis induced by Cas-Br-E in
mice has been well described and was previously studied in
our laboratory. Furthermore, the relatively long latency for
development of a disease in animals inoculated with this
strain should help discriminate between viral mutants with
slightly altered virulence. Interestingly, as is the case of HIV
in humans, the Cas-Br-E virus can be transmitted in mice
during mating between infected males and uninfected
females (Portis et al., 1987).
An infectious Cas-Br-E proviral DNA clone, initially
obtained by cloning a provirus from a virus-induced mouse
tumor (Bergeron et al., 1991), was used to generate specific
mutations in the YXXØ motif by site-directed mutagenesis.
Retroviruses can often evolve quite rapidly by mutations
when selective pressure is present and artificially introduced
mutations will revert if allowed to do so (see, e.g., Gran-
owitz et al., 1996). To maximize our chances of obtaining
stable mutants altered in the tyrosine-based signal, two
different mutations were thus designed (Fig. 1B). In theFig. 1. Tyrosine-based, YXXØ, motif in MuLV envelope glycoprotein
intracytoplasmic domain. (A) The intracytoplasmic domain of envelope
glycoprotein from various murine leukemia viruses, exhibiting different
tropism, was aligned, showing conservation of the tyrosine-based motif.
Asterisks indicate the end (stop codon) of the protein. Accession numbers:
Cas-Br-E: VCMVCB, Moloney: VCVWEM, Wild mice ecotropic:
AAD34534, Rauscher: NP_044739, RadLV: VCMVKA, AKV: A46511,
Friend: VCMVPV, SL3-3: AF169256, Amphotropic: AA061196, SRS19-6:
AAC98549, Xenotropic: AAA46531, MCF: AAA46528. (B) The amino
acids sequence of ecotropic Cas-Br-E encompassing the YXXØ motif is
presented; cleavage resulting in release of the R peptide in virions is
indicated by an arrow. The two mutants studied herein are presented below
the wild-type sequence with either substitution or deletion indicated in
white on black background.first simpler one, the tyrosine codon ‘‘TAT’’ was substituted
by a ‘‘TCT’’ serine codon (Y651S mutant); in the second
construct, the whole ‘‘TAT’’ triplet was deleted (DY651).
Both mutants were produced by site-directed mutagenesis
on a plasmid containing a portion of proviral DNA encom-
passing the envelope-encoding region, as described in
Materials and methods. The appropriate fragment was then
reinserted to restore a full-length proviral DNA. The muta-
tions introduced do not affect function or cleavage of the R
peptide (Aguilar et al., 2003; Li et al., 2001; Yang and
Compans, 1997). As a control, an additional mutant that
introduces a premature stop codon at position 630, thus
deleting the complete intracytoplasmic domain, including
the R peptide, was also constructed.
Importance of YXXØ in basolateral targeting of MuLV
virions
Although Moloney MuLV envelope glycoprotein was
shown to restrict the release of pseudotyped HIV-1 virions
to the basolateral surface of polarized epithelial cells via its
YXXØ motif (Lodge et al., 1997a), it was still of importance
to verify if this holds true in the Cas-Br-E envelope, and
importantly in the context of a complete MuLV proviral
DNA.
The ability of the envelope glycoprotein of Cas-Br-E to
target budding and release of HIV-1 virions, as previously
observed with the Moloney envelope glycoprotein (Lodge
et al., 1997a), was first established by cotransfection of Cas-
Br-E proviral DNA and envelope-negative HIV-1 proviral
DNA in MDCK cells. Because envelope-negative HIV-1
virions are released from both apical and basolateral surfa-
ces, basolateral targeting will only be observed if the Cas-
Br-E envelope glycoprotein is incorporated to these virions
and harbors an adequate targeting signal. Only the wild-
type envelope glycoprotein was able to target HIV-1 bud-
ding to the basolateral surface of epithelial cells, both
mutants altered in their tyrosine-based signal were unable
to target HIV-1 budding (Fig. 2A). In parallel, the Cas-Br-E
proviral constructs were separately introduced in MDCK
cells and infectious virions released from apical and baso-
lateral surface was measured using classical XC plaque
assay as described in Materials and methods. Again, infec-
tious wild-type virions, thus virions harboring the envelope
glycoprotein, were released exclusively from the basolateral
surface while infectious virions were released from both
surfaces in cells transfected with either mutant proviral
DNA (Fig. 2B). As with other retroviruses, basolateral
release of infectious Cas-Br-E virions is thus promoted by
the envelope glycoprotein and is dependent on a tyrosine-
based targeting motif.
In vitro replication of mutant MuLVs
Wild-type cloned proviral DNA and mutants were then
transfected into mouse NIH-3T3 fibroblasts permissive for
Fig. 2. Polarization of Cas-Br-E envelope glycoprotein and viral budding.
(A) Wild type or mutant Cas-Br-E proviral DNA was co-introduced with
envelope-negative HIV proviral DNA using lipofection of filter-grown
MDCK cells. Apical and basolateral media were collected and HIV virions
quantitated using a p24 ELISA assay. (B) Wild type or mutant Cas-Br-E
proviral DNAwas introduced in MDCK cells, apical and basolateral media
were collected, and infectious MuLV virions were quantitated using the XC
plaque assay. A representative experiment is presented.
Fig. 3. In vitro replication of MuLV mutants. Wild type or mutant proviral
DNAs were introduced by transfection in NIH-3T3 cells. Kinetic of viral
replication was determined by measuring reverse transcriptase activity in
the viral pellet recovered from the cell supernatant at different time intervals
following transfection, as described in Materials and methods.
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passaged at a fixed cell density and overnight media were
recovered from actively growing cells to ensure adequate
comparisons between the three viruses. Viruses exhibited a
growth phase from day 3 post-transfection up to around day
12 at which time viral production apparently peaked and
stayed constant thereafter, indicating that a stable chronic
infection was established, with most or all cells infected and
permanently releasing virus (Fig. 3). Although similar peak
virus replication was reached in all case, a small delay was
observed with the virus harboring a deletion of the tyrosine
residue. Replication kinetic of this virus in cells infected at the
same multiplicity of infection also suggests a short delay that
was rapidly abolished at the second passage of infected cells(data not shown). There was no difference in virus production
between viruses in chronically infected cell lines, and no
apparent formation of syncytia, indicating that the R peptide
is functional in these cells. Chronically infected cells were
similarly obtained three times and similar virus production
was always observed (data not shown). In contrast with these
viruses exhibiting apparently normal replication, the control
construct, lacking the whole intracytoplasmic domain, pro-
duced abundant syncytia 48 h post-transfection and exhibited
a long delay before viral replication could be detected (data
not shown).
Viral stocks for injection were recovered from chronically
infected cells under rapid harvest conditions (see Materials
and methods). An aliquot of these stocks was also used in a
RT-PCR reaction to verify if mutations were stably main-
tained; the final PCR product was directly sequenced in each
case. There was no change in the predicted sequence in three
independent experiments establishing chronically infected
cell lines for each virus. In contrast, the mutant lacking the
R peptide and showing a delayed multiplication exhibited
reversion of its stop codon upon extended passage (data not
shown), showing that the approach is adequate to demon-
strate reversion when these do occur.
Role of YXXØ in MuLV envelope glycoprotein expression
Although various retroviruses harbor the YXXØ motif,
the correlation between the presence of the YXXØ motif
and downmodulation of cell surface envelope glycoprotein
was only established for few retroviruses. Expression
level and stability of the mutant glycoproteins were thus
assessed first by immunoblotting of total protein samples;
the levels were shown to be similar with that of wild
type, either in transfected COS cells or infected NIH-3T3
cells few days post-infection (Fig. 4A). The level of cell-
Fig. 4. Expression of MuLV envelope glycoprotein mutants. (A) COS cells
were transiently transfected with either wild type or mutant proviral
construct. In parallel, NIH-3T3 cells were infected, at an MOI of 10, using
viruses harvested from chronically infected cells and tittered, as described
in Materials and methods. Proteins were recovered by cell lysis and
analyzed by immunoblotting using anti-Rauscher gp70, as described in
Materials and methods. (B) NIH-3T3 cells were infected as in panel A and
analyzed for the presence of cell surface viral glycoprotein by FACS
analysis. Mock control is a sample of uninfected NIH-3T3 cells that was
processed with both primary and secondary antibodies as for infected cells.
Identical results were obtained in two independent experiments.
Fig. 5. Development of disease in mice inoculated with MuLV envelope
glycoprotein mutants. Infectious viruses were prepared from chronically
infected NIH-3T3 cells and tittered as described in Materials and methods.
Newborn NIH/Swiss mice were intraperitoneally injected and sacrificed at
first evident sign of disease. (A) Results are presented as percentage of
death with time. (B) Each animal is separately represented, median time for
development of disease is indicated by a vertical bar. Wild-type results are
from three litters (n = 17), mutant results are from two litters each (n = 12
and 15 for Y651S and DY651, respectively). The difference in mean
latency time between DY651 and wild-type virus latency was found to be
significant at P < 0.05 (Wilcoxon rank-sum test).
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was next examined. Cells were infected with the different
viruses at the same multiplicity of infection. A polyclonal
antibody directed against MuLV was applied directly onto
live cells in an indirect immunofluorescence technique
and examined by FACS. All three viruses generated
similar percentage of positive cells and similar levels of
expression of the glycoprotein detected at the cell surface
by this approach (Fig. 4B).
Pathogenesis of MuLV mutants in inoculated mice
Wild type or mutant viruses of similar titers recovered
from chronically infected NIH-3T3 cells were then injected
into newborn NIH/Swiss mice. Two or three different litterswere used giving us between 12 and 17 animals for each
virus. All three viruses induced a disease in injected animals
that were sacrificed at first obvious signs of the disease
(labored breathing, ruffled hairs, enlarged spleen on palpa-
tion). Control animals were inoculated with tissue culture
medium from mock-transfected NIH-3T3 cells that do not
produce virus; these animals never developed the disease
and remained normal throughout the course of the experi-
ment. A significant increase in the time required for devel-
opment of the disease (P < 0.05 using the Wilcoxon rank-
sum test) was noted in animals inoculated with the DY651
virus (Fig. 5 and Table 1). There also appears to be more
variation in latencies between animals inoculated with either
Table 1
Disease induced by MuLV mutants of the tyrosine-based motif
Mean latency
(days)
% Splenomegaly
mean weight
% Enlarged
thymus
% Enlarged
lymph nodes
Wild type 182 100% 5 5
(n = 17) 1.77 g
Y651S 181 85% 40 60
(n = 12) 1.50 g
DY651 216 85% 35 55
(n = 15) 1.45 g
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inoculated with the wild type. In addition to the difference in
latency for development of full-blown disease, there was a
striking difference in the nature of the disease induced.
Splenomegaly was the major observed sign of disease in
animals infected with wild-type virus, as previously
reported (Bergeron et al., 1991). Both mutants also induced
splenomegaly in most, but not all inoculated animals; on
average, spleen weight was thus lower in these animals
although statistical significance could not be established.
The most striking difference observed was the development
of hypertrophied lymph nodes in essentially 60% of animals
inoculated with the mutants and the presence of thymomas
in approximately 40% of these animals. Overall, 75% of
animals inoculated with either mutant virus exhibited thy-
mic or lymph node hypertrophy while it was essentially
never observed in animals inoculated with the wild-type
virus (Table 1).
Sequencing of viruses recovered from diseased animals
Retroviruses can evolve, sometimes rapidly, accumulat-
ing or reverting mutations introduced in their genome.
Although such reversions were not observed during culti-
vation of the viruses in vitro, it could not be excluded that
reversion or secondary mutation(s) can occur in vivo. This
was examined by direct sequencing of RT-PCR product
obtained from viral RNA extracted from blood samples
recovered from mice at sacrifice. Five animals inoculated
with the deletion mutant were analyzed. All showed deletion
of the ‘‘TAT’’ tyrosine codon and no new changes were
observed in the DNA sequence encoding the transmembrane
and intracytoplasmic domain of the glycoprotein. Similar
results were obtained with the 11 Y651S substitution
mutants that were examined. In two cases, the presence of
a small peak in electrophoregrams suggests the partial
occurrence of reversion in animal inoculated with the
substitution mutant, although these peaks always repre-
sented less than 20% of total viruses. Cloning and sequenc-
ing of the PCR product in one case showed no reversion in
five clones that were sequenced. A PCR analysis of chro-
mosomal DNA in the spleen, hypertrophied thymus, and
hypertrophied lymph nodes in few animals also confirmed
the presence of integrated viral DNA with the expected
mutation (data not shown).Discussion
Despite its conservation in HIV isolates (Lodge et al.,
1997b and unpublished data) and its presence in many
retroviral envelope glycoproteins (Lodge et al., 1997a),
the exact importance of the membrane proximal YXXØ
targeting motif in viral pathogenesis remains uncertain. In
the present study, the Cas-Br-E murine leukemia virus was
used, as a possible model to investigate this question.
Tyrosine-based motifs can act as both a targeting motif to
specific cell surface membrane domains, or as an endocy-
tosis motif. This dual nature is shared by the HIV and SIV
envelope glycoproteins (Berlioz-Torrent et al., 1999; Boge
et al., 1998; Bowers et al., 2000; Egan et al., 1996;
LaBranche et al., 1995; Marsh et al., 1997; Ohno et al.,
1997; Sauter et al., 1996). In contrast, although there are still
controversial data in the literature, most recent evidence
suggest that there is no endocytosis of the MuLV envelope
glycoprotein (Grange et al., 2000). Our results, using
infected cells rather than various expression systems, also
confirmed that there is no change in either intracellular or
cell surface MuLV envelope glycoprotein levels when the
tyrosine-based motif was inactivated by mutation or deletion
(Fig. 4), suggesting again that there is no significant
endocytosis of the MuLV envelope glycoprotein from the
cell surface. There is also evidence that the glycine residue
upstream of YXXØ is essential to endocytosis in HIV and
SIV; this residue is conserved in HIV and SIV isolates, but
absent in MuLV, also supporting the idea that the motif may
not be active in endocytosis. Altogether, this indicates that
any effect of altering the tyrosine-based motif in MuLV
should be due to altered polarized targeting rather than
altered transport expression or stability of the glycoprotein
at the cell surface.
As previously observed with HIV-1 and SIV (Lodge et
al., 1994), amino acid substitution of the critical tyrosine
residue in YXXØ did not affect noticeably virus replica-
tion in vitro using standard replication assay. More re-
cently, it has been reported that amino acid substitution of
the tyrosine residue produce only a limited (less than 2-
fold) decrease of MuLV infectivity in a single-cycle assay
(Taylor and Sanders, 2003); the mutants used in the
present study were tested in a similar assay and confirmed
these results (data not shown). However, cell culture
conditions are possibly suboptimal to reveal subtle differ-
ences in viral replication kinetics or transmission. In fact,
in limiting conditions when infected cells producing small
amounts of HIV are co-cultivated with uninfected cells,
wild-type viruses are more efficiently transmitted than
mutants of the tyrosine-based motif (Deschambeault et
al., 1999), although cell-free viruses have similar infectiv-
ity. The analogous motif also favors in vitro transmission
of the HTLV-I virus from infected to uninfected cells
(Delamarre et al., 1999). Additional work will be required
to examine more closely the replication of MuLV mutants
under different conditions; however, it can never be
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evidenced in vivo.
In macaques inoculated with SIV mutants, reversion or
introduction of additional, probably compensatory, amino
acids substitutions were observed, although there was no
defect in viral replication in vitro (Fultz et al., 2001). The
small number of macaques used in the latter study, as well
as the different pathogenesis induced by SIV, renders
difficult any comparisons with the data presented herein.
Nevertheless, there seems to be a difference in the stringen-
cy of selective pressure to revert mutation of the tyrosine-
based motif in MuLV compared to SIV. In the MuLV model,
no second-site mutations were observed, and mutations
were stably maintained in the blood of inoculated animals.
The apparent absence of reversion in the MuLV model may
be explained in part by differences in the trafficking of
MuLV envelope glycoprotein compared to SIV glycopro-
tein, the former apparently lacking an endocytosis signal.
It has been shown with different proteins that dual
tyrosine-based endocytosis/polarization motifs can have
their activity modulated by neighboring amino acids (see,
e.g., Aroeti et al., 1993; Eberle et al., 1991; Geffen et al.,
1993; Lin et al., 1997; Matter et al., 1994; Prill et al., 1993).
This probably results from differential interaction of the
signal with a different set of adaptins, cellular proteins
mediating the interactions of proteins with the clathrin
vesicles (Boehm and Bonifacino, 2001; Bonifacino and
Dell’Angelica, 1999; Heilker et al., 1996; Lin et al., 1997;
Ohno et al., 1998; Sugimoto et al., 2002). The MuLV/mouse
model should be adequate to study the relative importance
of polarized targeting and endocytosis in vivo, using sig-
nificant number of animals in a well-defined experimental
system, a result clearly more difficult to achieve in the
complex SIV/macaque model. Work is currently under
progress to introduce mutations favoring endocytosis of
the viral glycoprotein in MuLV to study this point.
Although both substitution and deletion mutants were
able to induce disease in mice, further work will be needed
to explain altered kinetic of disease induction in deletion
mutant only. Small replication defect, which could be more
critical in vivo, rather than loss of the YXXØ motif per se,
could be responsible for the delay observed in development
of the disease.
The overall profile of the induced disease was strikingly
altered for mutant viruses compared to wild type. There was
no mention of such a change in the pattern of viral-induced
disease when the YXXØ motif was altered in SIV. Involve-
ment of additional organs, thymus and lymph nodes, was
similar in both mutant viruses and virtually never observed
with wild-type virus. Random rather than targeted viral
egress could be responsible for this change in the pattern
of virus-induced disease and most easily evidenced in the
absence of endocytosis. The phenotype observed is also
somewhat reminiscent of the situation observed with Sendai
virus, when a loss of the polarized budding phenotype leads
to viral propagation at organs not originally targeted by thevirus (Tashiro et al., 1992). Altogether, the tyrosine-based
YXXØ targeting motif thus appears of outmost importance
in vivo for the development of viral and retroviral-induced
disease.
Another aspect that deserves to be studied in the murine
model is the question of viral transmission and infection at
mucosal surfaces. The role of epithelial cells in retroviral
transmission at mucosal surfaces remains controversial and
is of outmost importance in the context of the AIDS
pandemics. Obviously, basolateral targeting of virus bud-
ding could have a major impact on the ability of a virus to
be transmitted via this route. In immunodeficiency virus,
HIV and SIV, numerous reports exist on viral transmission
through intact mucosal surfaces suggesting a role for epi-
thelial cells (e.g., Joag et al., 1997; Miller and Hu, 1999).
The presence of virus has also been detected by different
methods in cells of the intestinal mucosa (Gill et al., 1992;
Heise et al., 1991). In tissue culture, epithelial cells derived
from such different tissues as the thymus, liver, kidney, and
lung can be infected (Levy, 1993). Furthermore, it cannot be
excluded that some cells that are refractory to infection by
cell-free virus could be infected when placed in contact with
infected cells (Tan et al., 1993), as is the case in the context
of viral transcytosis across a tight monolayer of epithelial
cells (Bomsel, 1997; Hocini and Bomsel, 1999; Lagaye et
al., 2001). Recent observations on infection of epithelial
cells derived from the female genital tract (e.g., Asin et al.,
2003; Yeaman et al., 2003) further support the importance of
looking more closely at the infection and viral assembly in
the epithelial cells model. The MuLV/mice model could be
eventually applied to study sexual transmission of wild type
and mutant viruses because the Cas-Br-E virus was shown
to be transmissible by this route (Portis et al., 1987).Materials and methods
Viruses, cells, and animals
The Cas-Br-E infectious cloned proviral DNA in pBlue-
script (clone 77) was previously described (Bergeron et al.,
1991). All cell lines were originally obtained from the
American Type Culture Collection and were kept in media
containing fetal calf serum, except for NIH-3T3 cells that
were routinely kept in calf serum but were fed with fetal calf
serum for virus production (see rapid harvest procedure,
below). NIH/Swiss mice were obtained from the NIH
resource facilities (Bethesda, MD) and were kept in our
breeding colony.
Site-directed mutagenesis
The original cloned proviral DNA in pBluescript was
first digested with NdeI removing most of cellular DNA in 5V
of the provirus up to nucleotides 5774 in proviral DNA
(located in pol) and recircularized. In parallel, a fragment of
C. Danis et al. / Virology 324 (2004) 173–183180the env gene up to the beginning of the 3VLTR (from BamHI
at position 7231 to NheI at position 8195) was subcloned in
pBR322. Two mutagenic primers were designed to either
substitute the tyrosine residue at position 651 for a serine or
delete the whole nucleotide triplet encoding the tyrosine
residue (oligonucleotides 5V-GGGTTTCAGCTGGTGA-
GATTGCTG-3V and 5V-CAGCTGGTGTTGCTGAGT-
CAAAACC-3V, respectively). Control mutant in which a
premature stop codon was introduced at amino acid 630,
thus eliminating the whole intracytoplasmic domain encom-
passing the R peptide, was also prepared, using oligonucle-
otide 5V-CAAATTGGAGAATTCAATTGAGAATGC-3V.
Each of these mutagenic primers was used in the first
PCR reaction using the pBluescript construct as template
together with the upstream primer 5V-CCCAGGAG-
TGTTGGTTATGCC-3V in the proviral DNA upstream of
the BamHI site. The resulting fragment was used as up-
stream megaprimer in the second PCR reaction using the
envelope construct in pBR322 as the template with down-
stream primer 5V-GGCATAGGCTTGGTTATGCCG-3Vlocat-
ed in the pBR322 vector sequence. This last primer was
used together with the first upstream primer to further
amplify the desired fragment in a third PCR reaction. The
use of two different vectors as templates reduces back-
ground by amplification of the PCR product only because
the two primers used in the last PCR reaction could not
generate an amplification product from either of these
plasmids. The final resulting PCR fragment was digested
with BamHI and NheI to generate a fragment that was
substituted in the pBluescript construct. Finally, to recon-
stitute complete proviral DNA, each mutant construct was
digested with NdeI and the 5V NdeI fragment from the
original cloned proviral DNAwas introduced in the plasmid
construct.
Establishment of chronically infected cells
Wild type and mutant proviral DNAs were introduced
into semiconfluent NIH-3T3 cells using the calcium-phos-
phate coprecipitation procedure. Cells were passaged each 3
days, medium was changed the next day, and virus recov-
ered from cell supernatant to measure progress of viral
replication using a reverse transcriptase assay to quantitate
the virus. Cells were considered as chronically infected
when reverse transcriptase values remained constant upon
passage.
Production of infectious viruses
The rapid harvest procedure was used to produce high-
titer virus stocks from chronically infected cells. Briefly, a
small volume of complete medium containing fetal calf
serum (2 ml on a 10-cm-diameter petri dish) was applied
onto subconfluent cells, harvested after 2–3 h of incuba-
tion, and replaced with fresh medium. Supernatants col-
lected throughout the day were kept on ice and pooled atthe end of the day, aliquoted, and quickly frozen in liquid
nitrogen.
Quantitation and titration of viruses
For viral quantitation of total viruses released, virus-
containing supernatants were subjected to low-speed centri-
fugation to remove cellular debris (15 min at 3000 rpm in a
Sorval SH 3000 rotor at 4 jC) and ultracentrifuged at 40000
rpm in a Beckman 70.1 Ti rotor at 4 jC. Viral pellets were
then resuspended overnight in 200 Al of TE (10 mM Tris–
HCl, pH 8.0; 1 mM EDTA, pH 8.0), 50 Al of each sample
was mixed with 50 Al of a cocktail reaction [final concen-
trations: 50 mM Tris–HCl, pH 8.2; 20 mM dithiothreitol
(DTT); 50 mM NaCl; 0.05% Nonidet P-40; 0.6 mM MnCl2;
10 AM dTTP; 20 nM of poly(A)x (dT)15 (Roche Molecular
Biochemicals); 0.4 ACi [3H]dTTP (ICN, 1000 Ci/mmol].
The reaction was incubated 2 h at 37 jC, and products were
precipitated by addition of 1 ml of 10% trichloroacetic acid
(TCA), and left on ice for 2 h. The trichloroacetic acid-
precipitable material was filtered (0.45 Am, Millipore),
filters were dried, and retained radioactivity was measured
in a Beckman LS 600 SC scintillation counter. Titration of
infectious virus, recovered by the rapid harvest procedure,
was done by immunofluorescence of infected cell focus 24
h post-infection, using a combination of 83A25 and H48
monoclonal antibodies (a generous gift from Leonard H.
Evans, NIAID, Montana) (Evans et al., 1990).
Determination of polarized budding phenotype
The wild type and the two different mutant MuLV
proviral DNAs were each co-transfected with envelope-
negative HIV proviral DNA in MDCK cells grown onto
semipermeable filters, using lipofection as previously de-
scribed (Lodge et al., 1997a). Establishment of trans-epi-
thelial electrical resistance was followed each day using a
Millipore-ERS system until resistance reached a maximum
(at least 500 ohms  cm2). The release of p24 HIV-1 major
capsid protein was quantitated in apical and basolateral
media using an ELISA immunoassay.
In parallel, wild type and mutant MuLV proviral DNAs
were each introduced by lipofection into MDCK cells and
infectious viruses were directly quantitated by the XC
plaque assay (Rowe et al., 1970). Briefly, NIH-3T3 permis-
sive mouse cells were infected with serial virus dilutions and
later overlaid with indicator rat XC cells. Methylene blue
staining was used 3–4 days later to reveal plaques resulting
from the formation of large syncytia on those cells.
Expression of envelope glycoprotein
NIH-3T3 cells were infected, at a multiplicity of infec-
tion of 10, passaged once 3 days post-infection, and
analyzed. Total expression of membrane glycoprotein was
determined by immunoblotting or cell surface expression by
C. Danis et al. / Virology 324 (2004) 173–183 181FACS analysis. For immunoblotting analysis, cells were
lyzed in RIPA buffer [10mM Tris–HCl (pH 7.4), 1 mM
EDTA, 100 mM NaCl, 1% Triton X-100, 0.1% sodium
dodecyl sulfate, 0.25% deoxycholate, 0.2% phenylmethyl-
sulfonyl fluoride] and proteins were analyzed by immuno-
blotting using a goat polyclonal antiserum directed against
Rauscher MuLV gp70 envelope glycoprotein, followed by
detection using a secondary phosphatase-conjugated anti-
goat immunoglobulin. Antigen–antibody complexes were
detected by enhanced chemiluminescence. For detection of
the protein present at the cell surface, infected cells were
processed by adsorption of the primary antibody onto live
cells at 4 jC for 1 h under gentle agitation and in the
presence of 1mM sodium azide to prevent internalization.
After extensive washing in PBS, FITC-conjugated second-
ary antibody was added for 30 min. This was followed again
by washing in PBS. Cells were finally scraped from the petri
dish and analyzed by FACS (Becton Dickinson, FACStar
cytofluorometer).
Inoculation of experimental animals
Newborn mice (less than 48 h old) were inoculated
intraperitoneally with approximately 5  104 PFU, in a
volume of 0.1–0.2 ml, of viruses from filtered culture
supernatants obtained by the rapid harvest procedure. The
inoculated animals were observed daily and sacrificed when
they showed signs of advanced disease.
Sequencing on viral RNA samples
RNA was extracted from 100 Al of blood sample using
Trizol LS reagent as recommended by the manufacturer
(InVitrogen). Viruses from tissue culture medium were
similarly extracted from viral pellets resuspended in 100
Al from 10 ml of supernatant recovered from a 10-cm-
diameter petri dish and concentrated by ultracentrifugation
(50000 rpm in a 70Ti Rotor for 1 h at 4 jC). Extracted viral
RNA from either source was then treated with Rnase-free
RQ1 DNAse (Promega). Reverse transcription was per-
formed using cloned MoMuLV reverse transcriptase as
recommended by the manufacturer (InVitrogen) using an
oligonucleotide corresponding to nucleotide positions
7813–7834 in a region located in 3Vof the envelope gene
on the viral genome. Half of the DNA product was then
used in a nested PCR amplification strategy using Pwo
DNA polymerase according to the manufacturer (Roche); all
PCR reactions were incubated in a PTC-200 thermocycler
(MJ Research) for 35 cycles (94 jC for 1 min, 50 jC for 2
min, 72 jC for 3 min) with a hotstart first step (94 jC for 5
min). The first pair of primers flanked the p15E coding
region (upstream primer positions 7927–7949 and down-
stream primer 7813–7834). One-tenth of the first reaction
was used in the second PCR reaction, using internal
oligonucleotides (upstream primer positions 7343–7365
and downstream primer positions 7726–7745). Using thisprotocol, the expected band of 380 base pairs with negligi-
ble background was found on agarose gels and no back-
ground was observed when a sample from a control mouse
was similarly treated (data not shown). All manipulations
were performed using filtertips in a biological safety cabinet
with prior UV irradiation of the working surface. Samples
were individually treated to further eliminate the risks of
cross-contamination. The PCR fragments were then directly
subjected to DNA sequencing at the sequencing service of
Universite´ Laval (SUCOF; Quebec City, Canada).Acknowledgments
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